ClinicalTrials.gg
CompletedNCT00141336Updated Jan 1, 2007

To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

A Phase 3 interventional study of Pregabalin in Seizure Disorder, Partial, sponsored by Pfizer. Completed at 103 sites in 2 countries. Open to participants aged 12 Years and older. Per ClinicalTrials.gov, last updated 2007-01-01.

Sponsored by Pfizer · Phase 3, Interventional, and Treatment

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
750
Allocation
Non-randomized
Ages
12 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-19

Among 18 studies testing pregabalin in Epilepsies, Partial — none open to participants now, none under way, none of them phase 3. Pregabalin · Epilepsies, Partial.

Enrollment
Largest of 18
750 · median 244
Started
1999
the only one that year
Phase 3
12 of 18
none open now
Registered
1st of 18
by date
Lead sponsor
7 of 18
Pfizer

Among the 18 studies testing pregabalin in Epilepsies, Partial, this one has the largest enrollment, is the only one that started in 1999, is one of 12 in phase 3, and was the 1st registered.

Epilepsies, Partial

243 studies on the registry are indexed under Epilepsies, Partial; 49 are open to participants now.

Browse Epilepsies, Partial studies →

Open to participants now

None of the 18 studies testing pregabalin in Epilepsies, Partial is open now. The open studies under Epilepsies, Partial, anywhere →

About pregabalin

Pregabalin: first FDA approval 2004 (LYRICA), first EMA approval 2004. What it is approved for, and how studies give it, is on its page →

Who these studies take

Of the 37 Epilepsies, Partial studies recruiting now, 9 (24%) set no upper age limit and 24 (65%) stop at 75 or younger; 17 take children under 18; 3 take healthy volunteers.

This study: 12 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 18 studies testing pregabalin in Epilepsies, Partial as a file.
02

Study summary

To evaluate the long-term safety and tolerability of pregabalin in patients with partial seizures.

03

Conditions studied

  • Seizure Disorder, Partial

Browse trials for

04

Who can participate

Ages eligible
12 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Must have met the inclusion criteria for preceding double-blind study
  • Have received double-blind study medication and wish to receive open-label pregabalin.

Exclusion criteria

Exclusion Criteria:

  • Cannot have absence seizures
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
750 participants

Interventions

06

What researchers measure

Primary outcomes

  1. Safety Tolerability

07

Study locations

103 sites
  • Pfizer Investigational Site
    Phoenix, Arizona 85013, United States
  • Pfizer Investigational Site
    Tucson, Arizona 85724, United States
  • Pfizer Investigational Site
    Bakersfield, California 93301, United States
  • Pfizer Investigational Site
    Berkeley, California 94705, United States
  • Pfizer Investigational Site
    Concord, California 94520, United States
  • Pfizer Investigational Site
    Covina, California 91723, United States
  • Pfizer Investigational Site
    El Cajon, California 92021, United States
  • Pfizer Investigational Site
    Encino, California 91436, United States
  • Pfizer Investigational Site
    La Mesa, California 91942, United States
  • Pfizer Investigational Site
    Marina del Ray, California 90292, United States
  • Pfizer Investigational Site
    Martinez, California 94553, United States
  • Pfizer Investigational Site
    Northridge, California 91325, United States
  • Pfizer Investigational Site
    Pinole, California 94564, United States
  • Pfizer Investigational Site
    Redondo Beach, California 90277, United States
  • Pfizer Investigational Site
    Sacramento, California 95816, United States
  • Pfizer Investigational Site
    Sacramento, California 95823, United States
  • Pfizer Investigational Site
    San Diego, California 92120, United States
  • Pfizer Investigational Site
    Santa Monica, California 90404, United States
  • Pfizer Investigational Site
    Walnut Creek, California 94598, United States
  • Pfizer Investigational Site
    Denver, Colorado 80218, United States
  • Pfizer Investigational Site
    Englewood, Colorado 80110, United States
  • Pfizer Investigational Site
    Danbury, Connecticut 06810, United States
  • Pfizer Investigational Site
    Miami, Florida 33173, United States
  • Pfizer Investigational Site
    Miami, Florida 33176, United States
  • Pfizer Investigational Site
    Orlando, Florida 32806, United States
  • Pfizer Investigational Site
    Tampa, Florida 33609, United States
  • Pfizer Investigational Site
    Atlanta, Georgia 30322, United States
  • Pfizer Investigational Site
    Chicago, Illinois 60611, United States
  • Pfizer Investigational Site
    Chicago, Illinois 60612, United States
  • Pfizer Investigational Site
    Chicago, Illinois 60640, United States
  • Pfizer Investigational Site
    Crestview Hills, Kentucky 41017, United States
  • Pfizer Investigational Site
    Louisville, Kentucky 40202, United States
  • Pfizer Investigational Site
    Ruston, Louisiana 71270, United States
  • Pfizer Investigational Site
    Baltimore, Maryland 21287, United States
  • Pfizer Investigational Site
    Detroit, Michigan 48202-2689, United States
  • Pfizer Investigational Site
    Golden Valley, Minnesota 55422, United States
  • Pfizer Investigational Site
    Minneapolis, Minnesota 55422, United States
  • Pfizer Investigational Site
    Jackson, Mississippi 39216, United States
  • Pfizer Investigational Site
    St. Louis, Missouri 63110, United States
  • Pfizer Investigational Site
    Las Vegas, Nevada 89102, United States
  • Pfizer Investigational Site
    Las Vegas, Nevada 89106, United States
  • Pfizer Investigational Site
    Concord, New Hampshire 03301, United States
  • Pfizer Investigational Site
    Dover, New Hampshire 03820, United States
  • Pfizer Investigational Site
    New Brunswick, New Jersey 08901, United States
  • Pfizer Investigational Site
    New Brunswick, New Jersey 08903, United States
  • Pfizer Investigational Site
    Ridgewood, New Jersey 07450, United States
  • Pfizer Investigational Site
    Albuquerque, New Mexico 87131-5021, United States
  • Pfizer Investigational Site
    Albuquerque, New Mexico 87131-5281, United States
  • Pfizer Investigational Site
    Albuquerque, New Mexico 87131, United States
  • Pfizer Investigational Site
    Bronx, New York 10467, United States
  • Pfizer Investigational Site
    Brooklyn, New York 11203, United States
  • Pfizer Investigational Site
    New York, New York 10021, United States
  • Pfizer Investigational Site
    Asheville, North Carolina 28803, United States
  • Pfizer Investigational Site
    Asheville, North Carolina 28806, United States
  • Pfizer Investigational Site
    Raleigh, North Carolina 27607, United States
  • Pfizer Investigational Site
    Winston-Salem, North Carolina 27103, United States
  • Pfizer Investigational Site
    Winston-Salem, North Carolina 37103, United States
  • Pfizer Investigational Site
    Cincinnati, Ohio 45219, United States
  • Pfizer Investigational Site
    Cincinnati, Ohio 45242, United States
  • Pfizer Investigational Site
    Columbus, Ohio 43210, United States
  • Pfizer Investigational Site
    Oklahoma City, Oklahoma 73104-5068, United States
  • Pfizer Investigational Site
    Medford, Oregon 97504, United States
  • Pfizer Investigational Site
    Portland, Oregon 97201, United States
  • Pfizer Investigational Site
    Portland, Oregon 97209, United States
  • Pfizer Investigational Site
    Portland, Oregon 97210, United States
  • Pfizer Investigational Site
    Philadelphia, Pennsylvania 19104, United States
  • Pfizer Investigational Site
    Philadelphia, Pennsylvania 19107, United States
  • Pfizer Investigational Site
    Pittsburgh, Pennsylvania 15212, United States
  • Pfizer Investigational Site
    Ridley Park, Pennsylvania 19078, United States
  • Pfizer Investigational Site
    Upland, Pennsylvania 19013, United States
  • Pfizer Investigational Site
    Cranston, Rhode Island 02920, United States
  • Pfizer Investigational Site
    Knoxville, Tennessee 37916, United States
  • Pfizer Investigational Site
    Memphis, Tennessee 38103, United States
  • Pfizer Investigational Site
    Dallas, Texas 75216, United States
  • Pfizer Investigational Site
    Dallas, Texas 75230, United States
  • Pfizer Investigational Site
    Dallas, Texas 75243, United States
  • Pfizer Investigational Site
    Fort Worth, Texas 76107-2699, United States
  • Pfizer Investigational Site
    Fort Worth, Texas 76107, United States
  • Pfizer Investigational Site
    Houston, Texas 77002, United States
  • Pfizer Investigational Site
    Houston, Texas 77025, United States
  • Pfizer Investigational Site
    Houston, Texas 77030, United States
  • Pfizer Investigational Site
    Lubbock, Texas 79410, United States
  • Pfizer Investigational Site
    San Antonio, Texas 78207, United States
  • Pfizer Investigational Site
    San Antonio, Texas 78229, United States
  • Pfizer Investigational Site
    Alexandria, Virginia 22304, United States
  • Pfizer Investigational Site
    Alexandria, Virginia 22311, United States
  • Pfizer Investigational Site
    Charlottesville, Virginia 22908, United States
  • Pfizer Investigational Site
    Roanoke, Virginia 24014, United States
  • Pfizer Investigational Site
    Roanoke, Virginia 24016, United States
  • Pfizer Investigational Site
    Sterling, Virginia 20165, United States
  • Pfizer Investigational Site
    Bellevue, Washington 98004, United States
  • Pfizer Investigational Site
    Bellvue, Washington 98004, United States
  • Pfizer Investigational Site
    Spokane, Washington 99202, United States
  • Pfizer Investigational Site
    Spokane, Washington 99204, United States
  • Pfizer Investigational Site
    Morgantown, West Virginia 26507, United States
  • Pfizer Investigational Site
    Marshfield, Wisconsin 54449, United States
  • Pfizer Investigational Site
    Milwaukee, Wisconsin 53226, United States
  • Pfizer Investigational Site
    Calgary, Alberta T2N 2T9, Canada
  • Pfizer Investigational Site
    Edmonton, Alberta T5G 0B7, Canada
  • Pfizer Investigational Site
    Edmonton, Alberta T5H 3V9, Canada

Showing the first 100 of 103 sites across 2 countries. Choose a country and city above to see the rest.

08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Nov 1999 and a completion of Jul 2005. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 30, 2005
First posted
Sep 1, 2005
Start
Nov 1999
Completion
Jul 2005
Last update
Jan 1, 2007
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
No changes since tracking began. The registry record was last updated on Jan 1, 2007, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00141336
Lead sponsor
Pfizer
First posted
Sep 1, 2005
Start date
Nov 1999
Completion
Jul 2005
Last update
Jan 1, 2007

Study contacts

Pfizer CT.gov Call Center
study director · Pfizer
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2006. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: Pregabalin

Start the discussion